1UK prospective Diabetes Study Group:Tight blood pressure and risk of macrovascular and microvascular complications in type2 diabetes:UKPDS38.BMJ,1998,317:703-713
2Hansson L,Zanchett A,Carruthers SSG,et al.For the hot study group:Effects of intensive blood pressure lowering and low does aspirin inpatients with hypertension:principal results of the Hypertension Optimal Treatment(HOT) randomized trial.Lancet,1998,351:1755-1762
3Yusuf S,Sleight P,PogueJ,etal.Effects ofan angiotens in converting enzyme inhibitor,ramipril,on cardiovascular eventsin high risk patients:theHeartOutcomes Prevention Evaluation StudyInvestigators.N Eng J Med,2000,342:145-153.
4Dahlof B,Devereux RB,Kjedsen SE,etal.For the life study group:Cardiovascularmorbidity andmortality in the Losartan Intervention Forendpoint Reduction inHypertensionstudy(LIFE):arandomized trialagainst atenolol.Lancet,2002,359:995-1003
5Pahor M.Therapeutic benefits of ACE inhibitor and the rantihypertensive drugs inpatients with type2 diabetes.Diabtes Care,2000,23:888-892
6ChobanianAV,BakrisGL,Black HR,et al.The seventh report of the jointnational comMittee on prevention,detection,evaluation,and treatment of highblood pressure.JAMA,289:2560-2572
7European Society of Hypertension Europea society of Cardiology Guidelines Committee2003 European Society of Hypertension EuropeanSociety of Cardiology guideline for the management of arterial hypertension.Hypertens 2003,21:1011-1053
8American Diabetes Association.Treatment of hypertension in adults with diabetes(Position Statement).Diabetes Care,2002,25:S71-S73
9ALHAT Collaborative Research Group.Major outcomes in high riskhypertension patients randomized to angiotensin converting enzyme inhibitor or calcium channelblocker vs diuretic:The Antihypertensiveand Lipid Lowering Treatment to Prevent Heart Attack Trial(ALLHAT).JAMA,2002,288:2981-2997
10Zanchelti A.European Lacidipine Study on Atherosclerosis.Eur HeartJ,2001,22:2033-2037
